Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P25
Within normal range
vs 3Y Ago
-1.6x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-33.73%
2024-216.56%
202329.24%
202220.69%
20210.00%